GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » PS Ratio

China National Accord Medicines (SZSE:000028) PS Ratio : 0.27 (As of May. 22, 2024)


View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, China National Accord Medicines's share price is ¥37.45. China National Accord Medicines's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥136.28. Hence, China National Accord Medicines's PS Ratio for today is 0.27.

The historical rank and industry rank for China National Accord Medicines's PS Ratio or its related term are showing as below:

SZSE:000028' s PS Ratio Range Over the Past 10 Years
Min: 0.17   Med: 0.45   Max: 1.35
Current: 0.29

During the past 13 years, China National Accord Medicines's highest PS Ratio was 1.35. The lowest was 0.17. And the median was 0.45.

SZSE:000028's PS Ratio is ranked better than
66.32% of 95 companies
in the Medical Distribution industry
Industry Median: 0.49 vs SZSE:000028: 0.29

China National Accord Medicines's Revenue per Sharefor the three months ended in Mar. 2024 was ¥34.37. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥136.28.

Warning Sign:

China National Accord Medicines Corp Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of China National Accord Medicines was 1.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 8.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.20% per year.

During the past 13 years, China National Accord Medicines's highest 3-Year average Revenue per Share Growth Rate was 174.60% per year. The lowest was -18.20% per year. And the median was 12.60% per year.

Back to Basics: PS Ratio


China National Accord Medicines PS Ratio Historical Data

The historical data trend for China National Accord Medicines's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines PS Ratio Chart

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.33 0.23 0.19 0.21

China National Accord Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.32 0.23 0.21 0.23

Competitive Comparison of China National Accord Medicines's PS Ratio

For the Medical Distribution subindustry, China National Accord Medicines's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines's PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's PS Ratio distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's PS Ratio falls into.



China National Accord Medicines PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

China National Accord Medicines's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=37.45/136.283
=0.27

China National Accord Medicines's Share Price of today is ¥37.45.
China National Accord Medicines's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥136.28.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


China National Accord Medicines  (SZSE:000028) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


China National Accord Medicines PS Ratio Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines